Arrhythmia Alliance News & Events
For Clinicians
Study finds the heart can terminate atrial fibrillation itself after local gene therapy
Atrial fibrillation is the most common heart rhythm disorder (arrhythmia). Treatment aims to restore the heart's normal rhythm and includes drugs, which are not effective in all patients, ablation, for which efficiency remains suboptimal in the long-term, and electric shocks, which are effective but painful and ...
Read more [links to external site]
European Society of Cardiology guidelines on syncope launched today at EHRA 2018
Barcelona, Spain – 19 March 2018: European Society of Cardiology guidelines on syncope were launched today at EHRA 2018 and published online in the European Heart Journal.1,2. Syncope is a transient loss of consciousness caused by reduced blood flow to the brain. Approximately 50 per cent of ...
Read more [links to external site]
London Arrhythmia Summit
Our aim is to give Electrophysiologists and Arrhythmia specialists an update and succinct review of all the important developments/changes in this arena over the past year. The programme is dedicated to highlight guideline changes and important studies that will impact daily practice as well as an opportunity to look ahead to new developments on the horizon. We aim to road map all the information to the relevant conferences and hence provide a comprehensive update.
Read more [links to external site]
Predicting recurrent atrial fibrillation after catheter ablation
Pulmonary vein isolation (PVI) is a cornerstone of catheter ablation (CA) for atrial fibrillation (AF), but the achievement of durable PVI lesion can be challenging, and PVI alone may be insufficient for successful rhythm control in approximately a third of patients who underwent CA of AF, resulting in a high ...
Read more [links to external site]
Race and stroke in an atrial fibrillation inception cohort: Findings from the Penn Atrial Fibrillation Free study
Stroke may be the initial manifestation of atrial fibrillation (AF). Limited studies, however, have evaluated racial differences in stroke before the diagnosis of AF.
Read more [links to external site]
Black Atrial Fibrillation Patients Have Increased Risks for Strokes
Compared with whites, blacks are at increased risk of developing an ischemic stroke either before or after diagnosis of atrial fibrillation (AF), according to a study published online in Heart Rhythm.
Read more [links to external site]
Catheter Ablation for Atrial Fibrillation with Heart Failure
Mortality and morbidity are higher among patients with atrial fibrillation and heart failure than among those with heart failure alone. Catheter ablation for atrial fibrillation has been proposed as a means of improving outcomes among patients with heart failure who are otherwise receiving appropriate treatment.
Read more [links to external site]
Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care
To assess the association between anticoagulation, ischaemic stroke, gastrointestinal and cerebral haemorrhage, and all cause mortality in older people with atrial fibrillation and chronic kidney disease.
Read more [links to external site]
Blood thinning drugs may raise stroke risk for some a-fib patients
New research suggests, but cannot prove, that blood thinning drugs may raise stroke risk for seniors with atrial fibrillation who also have kidney disease
Read more [links to external site]
Intra-Atrial Dyssynchrony During Sinus Rhythm Predicts Recurrence After the First Catheter Ablation for Atrial Fibrillation
The purpose of this study was to evaluate the usefulness of intra-atrial dyssynchrony as a marker of underlying left atrial (LA) remodeling to predict recurrence after the first atrial fibrillation (AF) ablation.
Read more [links to external site]
.png)
